CatalystWireBeta

Holding(s) in Company

In brief · summary, not quotable

Canaccord Genuity Group Inc. has notified Advanced Medical Solutions Group PLC of a change in its major holding, with its voting rights decreasing from 5.0007% to 4.9867% as of September 28, 2026. This reduction represents a total of 10,950,985 voting rights. The notification indicates an acquisition or disposal of voting rights, and the total number of voting rights in the issuer is 10,950,985.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your AMS notes

Non-UK issuer

  • Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rightsX

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii :

Details of person subject to the notification obligation iv

NameCANACCORD GENUITY GROUP INC
City and country of registered office (if applicable)VANCOUVER, CANADA

Full name of shareholder(s) (if different from 3.) v

NameDISCRETIONARY CLIENTS
City and country of registered office (if applicable)As above
5. Date on which the threshold was crossed or reached vi :28 SEPTEMBER 2026
6. Date on which issuer notified (DD/MM/YYYY):29 SEPTEMBER 2026
  • Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights of issuer vii
Resulting situation on the date on which threshold was crossed or reached4.98674.986710,950,985
Position prior to the placing.5.00075.0007
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)Number of voting rights ix% of voting rights
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB000453659410,950,9854.9867
SUBTOTAL 8. A10,950,9854.9867

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrumentExpiration date xExercise/ Conversion Period xiNumber of voting rights that may be acquired if the instrument is exercised/converted.% of voting rights
SUBTOTAL 8. B 1
Type of financial instrumentExpiration date xExercise/ Conversion Period xiPhysical or cash settlement xiiNumber of voting rights% of voting rights
SUBTOTAL 8.B.2
Name xv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Canaccord Genuity Group Inc.4.98674.9867
Canaccord Genuity Wealth Group Holdings Limited4.98674.9867
Canaccord Genuity Wealth Group Holdings (Jersey) Limited4.98674.9867
Canaccord Genuity Wealth (International) Holdings Limited0.00180.0018
Canaccord Genuity Wealth (International) Limited0.00180.0018
Canaccord Genuity Wealth Group Limited4.98494.9849
Canaccord Genuity Wealth Limited4.14254.1425
Canaccord Genuity Asset Management Limited0.84240.8424

In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

Additional information xvi

Place of completionBLACKPOOL, ENGLAND
Date of completion29 SEPTEMBER 2026

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note